Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity

Cancer Research

Volumn 63, Issue 5, 2003, Pages 1025-1033

  Pogue, Brian W ^a,d   O'Hara, Julia A ^b   Demidenko, Eugene ^c   Wilmot, Carmen M ^b   Goodwin, Isak A ^a   Chen, Bin ^a   Swartz, Harold M ^b   Hasan, Tayyaba ^d  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FIBROSARCOMA; HYPOXIA; MITOCHONDRION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; OXYGEN TRANSPORT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIOSENSITIVITY; TREATMENT OUTCOME; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BASAL METABOLISM; CELL HYPOXIA; CELL SURVIVAL; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; FEMALE; FIBROSARCOMA; MICE; MICE, INBRED C3H; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RADIATION TOLERANCE;

EID: 0037374596     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Weishaupt, K., Gomer, C., and Dougherty, T. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res., 36: 2326-2329, 1976.
2. Gibson, S. L., and Hilf, R. Interdependence of fluence, drug dose and oxygen on HPD induced photosensitization of tumor mitochondria. Photochem. Photobiol., 42: 367-373, 1985.
3. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
4. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst. (Bethesda), 90: 889-905, 1998.
5. Luksiene, Z., Kalvelyte, A., and Supino, R. On the combination of photodynamic therapy with ionizing radiation. J. Photochem. Photobiol. B Biol., 52: 35-42, 1999.
6. Allman, R., Cowburn, P., and Mason, M. Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck. Br. J. Cancer, 83: 655-661, 2000.
7. Scott, L. J., and Goa, K. L. Verteporfin. Drugs Aging, 16: 139-146; discussion, 147-138, 2000.
8. 2 changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comp. Biochem. Physiol. A, 132: 172-184, 2002.
9. Kostron, H. The interaction of hematoporphyrin derivative, light and ionizing radiation in a rat glioma model. Cancer (Phila.), 57: 964-970, 1986.
10. Moan, J., and Petersen, E. O. X-irradiation of human cells inculture in the presence of hematoporphyrin. Int. J. Radiat. Biol., 50: 107-109, 1981.
11. Bellnier, D., and Dougherty, T. J. Hematoporphyrin derivative photosensitization and γ-radiation damage interaction in Chinese hampster ovary fibroblasts. Int. J. Radiat. Biol., 50: 659-664, 1986.
12. Roberts, D. J. H., Cairnduff, F., Dixon, B., and Brown, S. B. The response of a rodent fibrosarcoma to combined treatment with photodynamic therapy and radiotherapy. Int. J. Oncol., 6: 197-202, 1995.
13. Ramakrishnan, N., Clay, M. E., Friedman, L. R., Antunez, A. R., and Oleinick, N. L. Post-treatment interactions of photodynamic and radiation-induced cytotoxic lesions. Photochem. Photobiol., 52: 555-559, 1990.
14. Dobler-Girdziunaite, D., Burkard, W., Haller, U., Larsson, B., and Walt, H. The combined use of photodynamic therapy with ionizing radiation on breast carcinoma cells in vitro. Strahlenther. Onk., 171: 622-629, 1995.
15. Kukielczak, B., Romanowska, B., and Bryk, J. γ Radiation and MC540 photosensitization of melanoma in the hamster's eye. Melanoma Res., 9: 115-124, 1999.
16. Berg, K., Luksiene, Z., Moan, J., and Ma, L. Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. Radiat. Res., 142: 340-346, 1995.
17. Winter, I., Overgaard, J., and Ehlero, N. The effect on photodynamic therapy alone and in combination with misonidazole or x-rays for management of retinoblastoma like tumor. Photochem. Photobiol., 47: 419-423, 1988.
18. Benstead, K., and Moore, J. V. The effect of combined modality treatment with ionising radiation and TPPS-mediated photodynamic therapy on murine tail skin. Br. J. Cancer, 62: 48-53, 1990.
19. Pogue, B. W., Pitts, J. D., Mycek, M-A., Sloboda, R. D., Wilmot, C. M., Brandsema, J. A., and O'Hara, J. A. In vivo NADH fluorescence monitoring as an assay for cellular damage in photodynamic therapy. Photochem. Photobiol., 74: 817-824, 2002.
20. Runnels, J. M., Chen, B., Ortel, B., Kato, D., and Hasan, T. BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and B1 integrin expression in ovarian cancer cells. Br. J. Cancer, 80: 946-953, 1999.
21. Morgan, J., and Oseroff, A. R. Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug Deliv. Rev., 49: 71-86, 2001.
22. Pogue, B. W., Paulsen. K. D., O'Hara, J. A., and Swartz, H. M. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazolehypoxia and Eppendorf measurements. Rad. Res., 155: 15-25, 2001.
23. Twentyman, P. R., Brown, J. M., Gray, J. W., Franko, A. J., Scoles, M. A., and Kallman, R. F. A new mouse tumor model system (RIF-1) for comparison of endpoint studies. J. Natl. Cancer Inst. (Bethesda), 64: 595-604, 1980.
24. Fenton, B. M., and Way, B. A. Vascular morphometry of KHT and RIF-1 murine sarcomas. Radiother. Oncol., 28: 57-62, 1993.
25. Busch, T. M., Hahn, S. M., Evans, S. M., and Koch, C. J. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3, 3, 3-trifluoropropyl)acetamide]. Cancer Res., 60: 2636-2642, 2000.
26. Liu, Y. H., Hawk, R. M., and Ramaprasad, S. In vivo relaxation time measurements on a murine tumor model: prolongation of T1 after photodynamic therapy. MRI (Magn. Reson. Imaging), 13: 251-258, 1995.
27. Goda, F., Bacic, G., O'Hara, J. A., Gallez, B., Swartz, H. M., and Dunn, J. F. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res., 56: 3344-3349, 1996.
28. 2 measurements by electron paramagnetic resonance oximetry. Radiat. Res., 150: 549-556, 1998.
29. Pogue, B. W., O'Hara, J. A., Liu, K. J., Hasan, T., and Swartz, H. M. Photodynamic treatment of the RIF-1 tumor with verteporfin with online monitoring of tissue oxygen using electron paramagnetic resonance oximetry. Proc. SPIE, 3601: 108-114, 1999.
30. Fingar, V. H., Mang, T. S., and Henderson, B. W. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Cancer Res., 48: 3350-3354, 1988.
31. Henderson, B. W., and Fingar, V. H. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem. Photobiol., 49: 299-304, 1989.
32. Fingar, V. H., Wieman, T. J., Park, Y. J., and Henderson, B. W. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy. J. Surg. Res., 53: 524-528, 1992.
33. Zaidi, S. I. A., Kenney, M. E., and Mukhtar, H. Photodynamic therapy of RIF-1 tumors with topical application of silicon phthalocyanine: evidence for induction of apoptosis during tumor ablation. Clin. Res., 41: A507-A507, 1993.
34. Bremner, J. C., Bradley, J. K., Adams, G. E., Naylor, M. A., Sansom, J. M., and Stratford, I. J. Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT). Int. J. Radiat. Oncol. Biol. Phys., 29: 329-332, 1994.
35. van Geel, I. P. J., Oppelaar, H., Marijnissen, J. P. A., and Stewart, F. A. Influence of fractionation and fluence rate in photodynamic therapy with photofrin or mTHPC. Radiat. Res., 145: 602-609, 1996.
36. Veenhuizen, R. B., and Stewart, F. A. The importance of fluence rate in photodynamic therapy: is there a parallel with ionizing-radiation dose-rate effects. Radiother. Oncol., 37: 131-135, 1995.
37. Tromberg, B. J., Orenstein, A., Kimel, S., Barker, S. J., Hyatt, J., Nelson, J. S., and Berns, M. W. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol., 52: 375-385, 1990.
38. Tromberg, B. J., Kimel, S., Orenstein, A., Barker, S. J., Hyatt, J., Nelson, J. S., Roberts, W. G., and Berns, M. W. Tumor oxygen tension during photodynamic therapy. J. Photochem. Photobiol. B Biol., 5: 121-126, 1990.
39. Foster, T. H., Murant, R. S., Bryant, R. G., Knox, R. S., Gibson, S. L., and Hilf, R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res., 126: 296-303, 1991.
40. Gibson, S. L., Van Der Meid, K. R., Murant, R. S., Raubertas, R. F., and Hilf, R. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res., 50: 7236-7241, 1990.
41. Gibson, S. L., Foster, T. H., Feins, R. H., Raubertas, R. F., Fallon, M. A., and Hilf, R. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary-carcinoma in nude-mice. Br. J. Cancer, 69: 473-481, 1994.
42. Hua, Z. X., Gibson, S. L., Foster, T. H., and Hilf, R. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res., 55: 1723-1731, 1995.
43. Reed, M. W., Wieman, T. J., Schuschke, D. A., Tseng, M. T., and Miller, F. N. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res., 119: 542-552, 1989.
44. Fingar, V. H., Wieman, T. J., Wiehle, S. A., and Cerrito, P. B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res., 52: 4914-4921, 1992.
45. Fingar, V. H., Kik, P. K., Haydon, P. S., Cerrito, P. B., Tseng, M., Abang, E., and Wieman, T. J. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br. J. Cancer, 79: 1702-1708, 1999.
46. Iinuma, S., Schomacker, K. T., Wagnieres, G., Rajadhyaksha, M., Bamberg, M., Momma, T., and Hasan, T. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res., 59: 6164-6170, 1999.
47. Major, A., Kimel, S., Mee, S., Milner, T. E., Smithies, D. J., Srinivas, S. M., Chen, Z., and Nelson, J. S. Microvascular photodynamic effects determined in vivo using optical doppler tomography. IEEE J. Sel. Top. Quan. Elec., 5: 1168-1175, 1999.
48. Olive, P. L., Vikse, C., and Trotter, M. J. Measurement of oxygen diffusion distance in tumor cubes using a fluorescent hypoxia probe. Int. J. Radiat. Oncol. Biol. Phys., 22: 397-402, 1992.
49. Secomb, T. W., Hsu, R., Ong, E. T., Gross, J. F., and Dewhirst, M. W. Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol., 34: 313-316, 1995.
50. Dewhirst, M. W., Secomb, T. W., Ong, E. T., Hsu, R., and Gross, J. F. Determination of local oxygen consumption rates in tumors. Cancer Res., 54: 3333-3336, 1994.
51. Gulledge, C. J., and Dewhirst, M. W. Tumor oxygenation: a matter of supply and demand. Anticancer Res., 16: 741-749, 1996.
52. Kessel, D., Luo, Y., Deng, Y., and Chang, C. K. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol., 65: 422-426, 1997.
53. Kessel, D., and Luo, Y. Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. B Biol., 42: 89-95, 1998.
54. Kessel, D., and Luo, Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ., 6: 28-35, 1999.
55. Oleinick, N. L., and Evans, H. H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res., 150: S146-S156, 1998.
56. Xue, L., He, J., and Oleinick, N. L. Promotion of photodynamic therapy-induced apoptosis by stress kinases. Cell Death Differ., 6: 855-864, 1999.
57. Richter, A. M., Waterfield, E., Jain, A. K., Canaan, A. J., Allison, B. A., and Levy, J. G. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol., 57: 1000-1006, 1993.
58. Swartz, H. M., Boyer, S., Gast, P., Glockner, J. F., Hu, H., Liu, K. L., Moussavi, M., Norby, S. W., Vahidi, N., Walczak, T., Wu, M., and Clarkson, R. B. Measurements of pertinent concentrations of oxygen in vivo. Magn. Reson. Med., 20: 333-339, 1991.
59. Liu, K. J., Gast, P., Moussavi, M., Norby, S. W., Vahidi, N., Walczak, T., Wu, M., and Swartz, H. M. Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc. Natl. Acad. Sci. USA, 90: 5438-5442, 1993.
60. O'Hara, J. A., Goda, F., Liu, K. L., Bacic, G., Hoopes, P. J., and Swartz, H. M. Oxygenation in a murine tumor following radiation: an in vivo electron paramagnetic resonance oximetry study. Radiat. Res., 144: 224-229, 1995.
61. 2 in a murine tumor after irradiation: an in vivo electron paramagnetic resonance oximetry study. Radiat. Res., 144: 222-229, 1995.
62. Demidenko, E. Asymptotoic properties of mixed effects models. In: T. G. Gregorie (ed.), Modeling Longitudinal and Spatially Correlated Data. New York: Kluewer Press, 1997.
63. Rice, J. A. Mathematical Statistics and Data Analysis. Belmont, CA: Duxbury Press, 1995.
64. Schmidt-Erfurth, U., Bauman, W., Gragoudas, E., Flotte, T. J., Michaud, N. A., Birngruber, R., and Hasan, T. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology, 101: 89-99, 1994.
65. Henderson, B. W., and Bellnier, D. A. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found. Symp., 146: 112-125; discussion, 125-130, 1989.
66. Cincotta, L., Szeto, D., Lampros, E., Hasan, T., and Cincotta, A. H. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem. Photobiol., 63: 229-237, 1996.
67. Henderson, B. W., Busch, T. M., Vaughan, L, A., Frawley, N. P., Babich, D., Sosa, T. A., Zollo, J. D., Dee, A. S., Cooper, M. T., Bellnier, D. A., Greco, W. R., and Oseroff, A. R. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res., 60: 525-529, 2000.
68. Berg, K., Steen, H. B., Winkelman, J. W., and Moan, J. Synergistic effects of photoactivated tetra(4-sulfonatophenyl)porphine and nocodazole on microtubule assembly, accumulation of cells in mitosis and cell survival. J. Photochem. Photobiol. B Biol., 13: 59-70, 1992.
69. Castro, D. J., Saxton, R. E., Haghighat, S., Reisler, E., Plant, D., and Soudant, J. The synergistic effects of rhodamine-123 and merocyanine-540 laser dyes on human tumor cell lines: a new approach to laser phototherapy. Otolaryngol. Head Neck Surg., 108: 233-242, 1993.
70. Dewhirst, M. W., Sim, D. A., Gross, J. F., and Kundrat, M. A. Effects of heating rate on normal and tumor microcirculatory function. In: R. Diller (ed.), Heat and Mass Transfer in the Microcirculation of Thermally Significant Vessels, pp. 75-80. American Society of Mechanical Engineers, 1986.